PP077. New prognostic marker for the risk to develop early-onset preeclampsia [0.03%]
PP077. 一种新的早发子痫前期发病风险预后标志物
Joost Schuitemaker,Jannes Woudenberg,Gerarda Wijbenga et al.
Joost Schuitemaker et al.
Introduction: ESM-1 plays a role in the regulation of angiogenesis and is released by activated endothelial cells. Objective: To test t...
PP074. Persistent proteinuria after a pre-eclamptic pregnancy [0.03%]
子痫前期妊娠后的持续性蛋白尿：前瞻性队列研究中的纵向观察结果（PREPPP）试验
Anna Roberts,Amanda Green,Pamela Loughna et al.
Anna Roberts et al.
Introduction: There is increasing evidence to suggest that both preeclampsia and microalbuminuria are linked to long term cardiovascular and renal disease [1,2]. ...
PP075. Poor renal function following hypertensive pregnancy: Older mothers and smaller babies [0.03%]
不良妊娠高血压史对肾功能的影响：高龄产妇和低体重婴儿
Anna Roberts,Amanda Green,Pamela Loughna et al.
Anna Roberts et al.
Introduction: There is increasing evidence that hypertensive pregnancy is a risk factor for renal disease [1]. Objectives: To examine t...
PP073. The diagnostics potential of integral rheography during the dynamic examination of body fluid sectors at puerperal women with preeclampsia [0.03%]
PUERPERAL妇女妊娠高血压综合征患者全身血液流变学动态检查各体液灌注区域诊断价值研究
Aleksey Pyregov,Galiya Jonboboeva
Aleksey Pyregov
Objectives: correction of infusion intravenous therapy to avoid body hyperhydration during the infusion therapy by estimating body's water sectors condition at puerperal women with preeclampsia, which were delivered by ca...
PP072. Development of polyphenols-containing nanoparticles for the treatment of vaginal inflammation [0.03%]
含多酚纳米颗粒的开发用于治疗阴道炎症
Purusotam Basnet,Natasa Skalko-Basnet,Martha Agnes Hentemann et al.
Purusotam Basnet et al.
Introduction: Vaginal inflammation during pregnancy is linked to miscarriage, preterm labour, placental dysfunction and perinatal complications. Despite the availability of several anti-inflammatory drugs, there is no gen...
Nancy Odden,M C P Roland,B Lorentzen et al.
Nancy Odden et al.
Introduction: Preeclampsia (PE) has been considered to be a maternal inflammatory response to pregnancy and may be hazardous for mother and child. Soluble urokinase Plasminogen Activator receptor (suPAR) is a non-specific...
PP070. Maternal cardiovascular profiling in the first trimester ofpregnancies complicated with gestation induced hypertension or fetal growth restriction [0.03%]
孕早期妊娠高血压和胎儿生长受限的孕妇心血管特征分析
Jolien Oben,Kathleen Tomsin,Anneleen Staelens et al.
Jolien Oben et al.
Introduction: Maternal cardiovascular (CV) profiling is useful in the assessment of gestational hypertensive disorders (GHD)(1). The onset of GHD occurs during the first weeks of gestation(2). ...
PP069. Hypertension evaluated by 24-hour ambulatory blood pressure measurements in previously preeclamptic women one year postpartum [0.03%]
产后1年之前患有子痫前期的妇女的24小时动态血压测量高血压评估
Annemarie G M G J Mulders,Eline C van der Wilk,Jorgo Lugthart et al.
Annemarie G M G J Mulders et al.
Introduction: Women with a history of preeclampsia have an increased risk of developing cardiovascular disease (CVD) later in life. 24-hour ambulatory blood pressure measurement is considered to be the gold-standard for d...
Eva Meler,Elena Murillo,Ignacio Rodriguez et al.
Eva Meler et al.
Introduction: It is well known that a multiparametric model including epidemiological maternal factors, uterine Doppler and biochemical parameters could be useful at 1st and 2nd Trimester for the prediction of early PE (
PP068. Evaluation of cardiovascular health in previously preeclamptic women [0.03%]
评估之前患有子痫前期的女性的心血管健康状况
Annemarie G M G J Mulders,Eline C van der Wilk,Samer R Khan et al.
Annemarie G M G J Mulders et al.
Introduction: Women with a history of preeclampsia have an increased risk of developing cardiovascular disease (CVD) later in life. Classical risk scores are not suitable as risk estimates of CVD in this young population....